WO2006031420A3 - Multi-layer tablets and bioadhesive dosage forms - Google Patents
Multi-layer tablets and bioadhesive dosage forms Download PDFInfo
- Publication number
- WO2006031420A3 WO2006031420A3 PCT/US2005/030651 US2005030651W WO2006031420A3 WO 2006031420 A3 WO2006031420 A3 WO 2006031420A3 US 2005030651 W US2005030651 W US 2005030651W WO 2006031420 A3 WO2006031420 A3 WO 2006031420A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- layer tablets
- dosage form
- retention time
- dosage forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002578845A CA2578845A1 (en) | 2004-08-27 | 2005-08-29 | Multi-layer tablets and bioadhesive dosage forms |
EP05792519A EP1784167A2 (en) | 2004-08-27 | 2005-08-29 | Multi-layer tablets and bioadhesive dosage forms |
US11/661,541 US20080311191A1 (en) | 2004-08-27 | 2005-08-29 | Multi-Layer Tablets and Bioadhesive Dosage Forms |
JP2007530225A JP2008516893A (en) | 2004-08-27 | 2005-08-29 | Multilayer tablets and bioadhesive dosage forms |
AU2005285298A AU2005285298A1 (en) | 2004-08-27 | 2005-08-29 | Multi-layer tablets and bioadhesive dosage forms |
Applications Claiming Priority (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60520004P | 2004-08-27 | 2004-08-27 | |
US60499104P | 2004-08-27 | 2004-08-27 | |
US60519804P | 2004-08-27 | 2004-08-27 | |
US60519904P | 2004-08-27 | 2004-08-27 | |
US60499004P | 2004-08-27 | 2004-08-27 | |
US60520104P | 2004-08-27 | 2004-08-27 | |
US60/604990 | 2004-08-27 | ||
US60/604991 | 2004-08-27 | ||
US60/605198 | 2004-08-27 | ||
US60/605201 | 2004-08-27 | ||
US60/605199 | 2004-08-27 | ||
US60/605200 | 2004-08-27 | ||
US60790504P | 2004-09-08 | 2004-09-08 | |
US60/607905 | 2004-09-08 | ||
US11/009,327 US20050201974A1 (en) | 2003-12-09 | 2004-12-09 | Bioadhesive polymers with catechol functionality |
US11/009,327 | 2004-12-09 | ||
US63581204P | 2004-12-13 | 2004-12-13 | |
US60/635812 | 2004-12-13 | ||
US65037505P | 2005-02-04 | 2005-02-04 | |
US65019105P | 2005-02-04 | 2005-02-04 | |
US60/650191 | 2005-02-04 | ||
US60/650375 | 2005-02-04 | ||
PCT/US2005/007525 WO2005084639A2 (en) | 2004-03-03 | 2005-03-03 | Polymeric drug delivery system for hydrophobic drugs |
USPCT/US2005/007525 | 2005-03-03 | ||
US67638305P | 2005-04-29 | 2005-04-29 | |
US60/676383 | 2005-04-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006031420A2 WO2006031420A2 (en) | 2006-03-23 |
WO2006031420A3 true WO2006031420A3 (en) | 2006-11-30 |
Family
ID=35703299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/030651 WO2006031420A2 (en) | 2004-08-27 | 2005-08-29 | Multi-layer tablets and bioadhesive dosage forms |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1784167A2 (en) |
AU (1) | AU2005285298A1 (en) |
CA (1) | CA2578845A1 (en) |
WO (1) | WO2006031420A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2086515A2 (en) * | 2006-03-02 | 2009-08-12 | Vaunnex, Inc. | Rate-controlled bioadhesive oral dosage formulations |
EP3620153A1 (en) | 2007-07-06 | 2020-03-11 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
WO2009008006A2 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
US20120027855A1 (en) | 2007-07-06 | 2012-02-02 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
JP2013169146A (en) * | 2012-02-17 | 2013-09-02 | Kabaya Shokuhin Kk | New refreshing confectionery and method for producing the same |
TWI439288B (en) * | 2012-10-05 | 2014-06-01 | Univ China Medical | Medicinal carriers and preparation method and uses thereof |
WO2014059309A1 (en) * | 2012-10-11 | 2014-04-17 | Theravida, Inc. | Pharmaceutical formulations of pilocarpine |
WO2015167434A1 (en) * | 2014-04-28 | 2015-11-05 | Eduardo Fernandez | Compositions for nutritional supplementation |
CN116159037B (en) * | 2023-04-25 | 2023-08-01 | 四川省川龙动科药业有限公司 | Targeted pellet composition for preventing and treating piglet colitis and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000112A1 (en) * | 1992-06-24 | 1994-01-06 | Astra Aktiebolag | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
US6123965A (en) * | 1996-01-26 | 2000-09-26 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
US6156348A (en) * | 1996-06-25 | 2000-12-05 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
US6197346B1 (en) * | 1992-04-24 | 2001-03-06 | Brown Universtiy Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
WO2002005820A1 (en) * | 2000-07-19 | 2002-01-24 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
US6391294B1 (en) * | 1997-08-21 | 2002-05-21 | Reckitt Benckiser Healthcare (Uk) Limited | In situ formation of polymeric material |
US6391335B1 (en) * | 1998-04-29 | 2002-05-21 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US20030113371A1 (en) * | 2001-08-21 | 2003-06-19 | Council Of Scientific & Industrial Research | Composition and method for maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition |
-
2005
- 2005-08-29 EP EP05792519A patent/EP1784167A2/en not_active Withdrawn
- 2005-08-29 CA CA002578845A patent/CA2578845A1/en not_active Abandoned
- 2005-08-29 WO PCT/US2005/030651 patent/WO2006031420A2/en active Application Filing
- 2005-08-29 AU AU2005285298A patent/AU2005285298A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197346B1 (en) * | 1992-04-24 | 2001-03-06 | Brown Universtiy Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
WO1994000112A1 (en) * | 1992-06-24 | 1994-01-06 | Astra Aktiebolag | An oral formulation for gastric antibacterial treatment as well as a process thereof and the use |
US6123965A (en) * | 1996-01-26 | 2000-09-26 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
US6156348A (en) * | 1996-06-25 | 2000-12-05 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
US6391294B1 (en) * | 1997-08-21 | 2002-05-21 | Reckitt Benckiser Healthcare (Uk) Limited | In situ formation of polymeric material |
US6391335B1 (en) * | 1998-04-29 | 2002-05-21 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
WO2002005820A1 (en) * | 2000-07-19 | 2002-01-24 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
US20030113371A1 (en) * | 2001-08-21 | 2003-06-19 | Council Of Scientific & Industrial Research | Composition and method for maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition |
Also Published As
Publication number | Publication date |
---|---|
WO2006031420A2 (en) | 2006-03-23 |
EP1784167A2 (en) | 2007-05-16 |
CA2578845A1 (en) | 2006-03-23 |
AU2005285298A1 (en) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006031420A3 (en) | Multi-layer tablets and bioadhesive dosage forms | |
CN1130194C (en) | Solid pharmaceutical preparation | |
WO2007031887A3 (en) | Extended release pharmaceutical composition of metformin and a process for producing it | |
JP2005511647A (en) | Compressed annular tablets with oral and oral molded powder tablets | |
WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
WO2006040779A3 (en) | Controlled release gastric floating matrix formulation containing imatinib | |
WO2006063189A3 (en) | Multi-layered chewing gum tablet with quick disintegration layer | |
WO2007079082A3 (en) | Gastric release pulse system for drug delivery | |
WO2007081948A3 (en) | Bioadhesive drug formulations for oral transmucosal delivery | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
PL211301B1 (en) | Orally-dispersible multilayer tablet | |
WO2006039499A3 (en) | Method for improving the biovailability of orally delivered therapeutics | |
ZA200701576B (en) | Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition | |
WO2002067903A3 (en) | Compositions and methods of manufacture for oral dissolvable dosage forms | |
JP2009536147A5 (en) | ||
WO2005112896A3 (en) | Dosage form for delivery of multiple drug forms | |
HK1111902A1 (en) | Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof | |
IL205262A (en) | Use of risedronic acid or pharmaceutically acceptable salt thereof for the manufacture of a medicament for oral administration on one day per month for the prevention or the treatment of osteoporosis | |
WO2007122635A3 (en) | Controlled release formulation comprising anti-epileptic drugs | |
WO2003065982A3 (en) | Engineering absorption of therapeutic compounds via colonic transporters | |
WO2007146805A3 (en) | Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty | |
CN107106498A (en) | method for producing drug delivery system | |
AU2004246837A1 (en) | Orally-dispersible multilayer tablet | |
IL187632A (en) | 17-ethynyl-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenantren-3-ylmethyl ester of acetoxy-acetic acid, pharmaceutical dosage unit comprising it and its use for the manufacture of a medicament for contraception | |
WO2007086079A3 (en) | Sustained release dosage form of phenothiazine derivatives containing channelizer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007530225 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2578845 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005285298 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005792519 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2005285298 Country of ref document: AU Date of ref document: 20050829 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005285298 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005792519 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11661541 Country of ref document: US |